Literature DB >> 3832533

The corneal endothelium and Descemet's membrane in the iridocorneal endothelial syndrome.

J M Portis, R L Stamper, W H Spencer, R G Webster.   

Abstract

A 39-year-old woman with progressive left unilateral glaucoma associated with corneal edema, iris changes, and peripheral anterior synechia formation underwent a left trabeculectomy and iridectomy in an attempt to control the intraocular pressure. Shortly after surgery the edema worsened despite low intraocular pressure measurements. A repeat trabeculectomy combined with a full thickness keratoplasty was performed 11/2 years later. The posterior corneal surface was found to be covered by a partially doubled layer of endothelial cells with ultrastructural features resembling epithelium. Similar cells were not noted on the surface of the initial trabecular meshwork and iris specimens, but were seen on the surface of the specimens obtained at the second trabeculectomy. The anterior and middle portions of Descemet's membrane, formed during perinatal and early adult life, appeared normal, but its posterior portion appeared abnormal. The ultrastructural changes in the endothelial cells and the abnormalities observed in Descemet's membrane suggest that the endothelial cells were initially normal but subsequently acquired epithelial-like features as they degenerated and proliferated. The continued presence of corneal edema despite the hypercellularity of the endothelium suggests that the proliferating cells were permeable to aqueous.

Entities:  

Mesh:

Year:  1985        PMID: 3832533      PMCID: PMC1298704     

Source DB:  PubMed          Journal:  Trans Am Ophthalmol Soc        ISSN: 0065-9533


  42 in total

1.  Atrophy of the stroma of the iris; endothelial dystrophy, corneal edema, and glaucoma.

Authors:  P A CHANDLER
Journal:  Am J Ophthalmol       Date:  1956-04       Impact factor: 5.258

2.  The corneal endothelium and the spectrum of essential iris atrophy.

Authors:  D G Campbell; M B Shields; T R Smith
Journal:  Am J Ophthalmol       Date:  1978-09       Impact factor: 5.258

3.  Benign orbital neurilemoma. Sarcomatous transformation in von Recklinghausen's disease.

Authors:  H Schatz
Journal:  Arch Ophthalmol       Date:  1971-09

4.  Progressive essential iris atrophy, Chandler's syndrome, and the iris nevus (Cogan-Reese) syndrome: a spectrum of disease.

Authors:  M B Shields
Journal:  Surv Ophthalmol       Date:  1979 Jul-Aug       Impact factor: 6.048

5.  The essential iris atrophies.

Authors:  M B Shields; D G Campbell; R J Simmons
Journal:  Am J Ophthalmol       Date:  1978-06       Impact factor: 5.258

6.  Electron microscopy in the diagnosis of malignant schwannoma.

Authors:  J B Taxy; H Battifora; Y Trujillo; H D Dorfman
Journal:  Cancer       Date:  1981-09-15       Impact factor: 6.860

7.  Light microscopic and ultrastructural observations of a metastasizing malignant epithelioid schwannoma.

Authors:  M M Alvira; T K Mandybur; M G Menefee
Journal:  Cancer       Date:  1976-11       Impact factor: 6.860

8.  Peripheral nerve sheath tumors: an electron microscopic study of 43 cases.

Authors:  R A Erlandson; J M Woodruff
Journal:  Cancer       Date:  1982-01-15       Impact factor: 6.860

9.  Proliferative endotheliopathy with iris abnormalities. The iridocorneal endothelial syndrome.

Authors:  R C Eagle; R L Font; M Yanoff; B S Fine
Journal:  Arch Ophthalmol       Date:  1979-11

10.  Corneal decompensation in Chandler's syndrome. A scanning and transmission electron microscopic study.

Authors:  T M Richardson
Journal:  Arch Ophthalmol       Date:  1979-11
View more
  2 in total

1.  Unique variations and characteristics of iridocorneal endothelial syndrome in China: a case series of 58 patients.

Authors:  Bo Feng; Xin Tang; Hong Chen; Xia Sun; Ningli Wang
Journal:  Int Ophthalmol       Date:  2017-10-10       Impact factor: 2.031

2.  Progression and regression of partial corneal involvement in the iridocorneal endothelial syndrome.

Authors:  W M Bourne; R F Brubaker
Journal:  Trans Am Ophthalmol Soc       Date:  1992
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.